Lymph Node Ratio and Kras Mutation in R Colon Cancer

• Status: Completed
• Trial end date: 2019-08-26
• Target enrollment: 0
• Participant gender: All

Summary

clinical impact of LN ratio with Kras expression in colon cancer

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mansoura University
• Treatments: Panitumumab

Criteria

Inclusion Criteria:

• Stage III colon cancer

Exclusion Criteria:

• Stage I, II, IV